Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the ...

The trial is enrolling adult women with recurrent ovarian cancer after at least two previous therapies. Credit: Jo Panuwat D / Shutterstock.com. (Jo Panuwat D / Shutterstock.com.) Anixa Biosciences ...

A new paper from MUSC Hollings Cancer Center researchers is helping to reveal the "rules" for engineering chimeric antigen receptor (CAR) Tregs. Tregs, or T-regulatory cells, have shown promise in ...

Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

Chimeric antigen receptor (CAR) T-cell therapy represents a paradigm shift in the treatment of relapsed or refractory haematological cancers by harnessing patients’ own immune cells to target surface ...

Impact of active cancer on mortality and complications after TAVR: A systematic review and meta-analysis. Characterization of the ctDNA mutational landscape in HER2-positive metastatic breast cancer ...

Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the ...

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

SHREVEPORT, La. – Ochsner LSU Health–Feist-Weiller Cancer Center is now offering CAR T-cell (Chimeric Antigen Receptor T-cell) therapy to eligible patients in Shreveport-Bossier and across North ...

Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.